April 24, 2014 5:32 PM ET

Biotechnology

Company Overview of Histogenics Corporation

Executive Profile

Peter S. Greenleaf

Chief Executive Officer and Director, Sucampo Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 3 Board Members in 3 different organizations across 7 different industries.

See Board Relationships
43--

Background

Mr. Peter S. Greenleaf has been Chief Executive Officer of Sucampo Pharmaceuticals, Inc. since March 03, 2014. Mr. Greenleaf has been Chief Executive Officer of Histogenics Corporation since June 10, 2013 and serves as its President. Mr. Greenleaf served as President of MedImmune, LLC (also known as MedImmune, Inc.). Mr. Greenleaf also served as President of MedImmune Ventures, a wholly owned venture capital fund within the AstraZeneca Group, where he led investment ...

Corporate Headquarters

830 Winter Street
Waltham, Massachusetts 02451

United States

Phone: 781-547-7900
Fax: 781-547-4452

Board Members Memberships

Former Director
Director
Chief Executive Officer and Director
Former Director
2010-N/A
Former Director
2014-Present
Chief Executive Officer and Director

Education

MBA
Saint Joseph's University
BA
Western Connecticut State University

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Howard W. Robin Chief Executive Officer, President and Director
Nektar Therapeutics
$807.7K
Peter M. Hecht Ph.D. Co-Founder, Chief Executive Officer and Director
Ironwood Pharmaceuticals, Inc.
$100.0K
Mark R. Baker J.D.Chief Executive Officer, Director, Member of Science & Technology Committee and Member of Strategy & External Technology Subcommittee
Progenics Pharmaceuticals, Inc.
$672.8K
Richard Martin Steeves BSc., Ph.D.Group Chief Executive Officer, Member of Senior Executive Board and Executive Director
Synergy Health plc
$778.0K
A. J. Kazimi MBAFounder, Chairman, Chief Executive Officer and President
Cumberland Pharmaceuticals, Inc.
$620.0K
Compensation as of Fiscal Year 2012.

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Histogenics Corporation, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.